PDLLA + HA Biostimulator (1 x 5ml Solution Vial + 1 x 100mg Vial)
PD-H 100 Powder | PDLLA + HA Biostimulator
PD-H 100 is a professional biostimulator powder formulated with Poly-D,L-lactic Acid (PDLLA) and Hyaluronic Acid (HA). It is designed to combine relatively rapid tissue integration with progressive collagen induction, balanced volume enhancement, and precise contouring.
PDLLA is distinguished by its amorphous molecular structure. Its mixed D- and L-lactic acid isomers prevent crystallization, supporting more uniform hydrolysis and predictable absorption within the tissue.
According to the supplied technical documentation, PDLLA has an approximate degradation period of 6–12 months and demonstrates a relatively fast onset compared with PLLA and PCL. This makes PD-H 100 particularly suited to applications where uniform integration, smooth contour improvement, and controlled collagen stimulation are desired.
Why PDLLA?
Rapid Integration Amorphous PDLLA supports uniform dispersion and relatively rapid integration within tissue.
Collagen Biostimulation Supports fibroblast activation and progressive formation of Type I and Type III collagen.
Balanced Volume Designed to support natural-looking volume enhancement without excessive volumization.
Precise Contouring Uniform tissue integration supports smooth texture improvement and refined contouring.
HA Synergy Hyaluronic acid provides an initial hydration matrix while helping promote uniform polymer-particle dispersion.
Progressive Remodeling Supports gradual tissue remodeling, elasticity, and structural improvement as collagen develops.
How PDLLA Biostimulation Works
4-Step Collagen Neogenesis Pathway
1
Microparticle Introduction Polymer particles are dispersed within the targeted tissue.
2
Foreign Body Response Macrophages and giant cells surround the biodegradable particles as part of the tissue response.
3
Fibroblast Activation The resulting signaling environment promotes fibroblast activity and collagen synthesis.
4
Tissue Remodeling Progressive collagen development supports gradual volume restoration and improved skin elasticity.
Designed for Precision
The supplied product guide positions PD-H 100 for cases requiring rapid integration and precise contouring. Its uniform tissue response and relatively fast integration profile make it particularly suited to detailed treatment planning where smooth contour enhancement is desired.
The manufacturer's technical material specifically identifies applications involving detailed lifting and contouring of areas such as the jawline and forehead.
*For Professionals only*
If you already possess a Dermafirm professional account, please log in to view the "Add to Cart" button and proceed to checkout.
If you have not yet registered, you can create a professional account by clicking the "Register Here" button below.
How to Use
For Professional Use Only PD-H 100 is a professional biostimulator powder intended for preparation and administration by an appropriately trained and qualified healthcare professional in accordance with applicable regulations.
Professional Treatment
Patient selection, product preparation, treatment area, dosage, administration technique, treatment depth, injection pattern, needle or cannula selection, and treatment interval should be determined by the treating professional based on patient anatomy, treatment objectives, professional training, and the manufacturer's official Instructions for Use.
Before Treatment
- Perform an appropriate patient consultation and medical assessment.
- Evaluate the treatment area and establish appropriate treatment goals.
- Review contraindications, precautions, and relevant medical history.
- Follow appropriate aseptic preparation and infection-control procedures.
- Prepare the product only according to the manufacturer's authorized Instructions for Use and professional training.
Professional Administration
Administer PD-H 100 using the technique and treatment parameters specified by the manufacturer and appropriate to the patient's anatomy and clinical objectives.
The supplied technical document describes PD-H 100 as particularly suited to treatment strategies requiring rapid integration, balanced volume, smooth tissue integration, and precise contouring.
Important Treatment Information
The supplied technical document does not specify an official reconstitution volume, injection depth, injection volume, needle/cannula size, or treatment interval. These parameters should therefore not be inferred from the technical presentation. Refer to the manufacturer's official PD-H 100 Instructions for Use before preparation or administration.
PD-H 100 Specifications
| Product | PD-H 100 Powder |
|---|---|
| Biostimulator | Poly-D,L-lactic Acid (PDLLA) |
| Matrix | Hyaluronic Acid (HA) |
| Polymer Structure | Amorphous |
| Polymer Content | 100 mg polymer + HA composite structure |
| Approx. Degradation Period | 6–12 months |
| Collagen Profile | Type I + Type III |
| Onset Profile | Relatively fast |
| Key Strength | Uniform integration and precise contouring |
| Primary Positioning | Rapid integration, balanced volume enhancement, smooth tissue integration, and precise contouring |
PDLLA Structural Advantage
PDLLA consists of mixed D- and L-lactic acid isomers. This amorphous structure prevents crystallization and allows simultaneous surface and internal hydrolysis, supporting relatively uniform degradation and absorption.
PDLLA + HA Synergy
In the supplied technical documentation, HA is described as more than a traditional filler component. It functions as a delivery matrix that creates an initial hydration environment and helps prevent particle aggregation.
This combination is designed to support more uniform polymer dispersion while creating an environment favorable to progressive collagen induction and tissue remodeling.
Ingredients
PD-H 100 combines Poly-D,L-lactic Acid (PDLLA) with Hyaluronic Acid (HA) to provide a biodegradable biostimulation platform designed for uniform tissue integration, hydration support, and progressive collagen induction.
Poly-D,L-lactic Acid (PDLLA)
A biodegradable polymer composed of mixed D- and L-lactic acid isomers. PDLLA's amorphous structure prevents crystallization and supports uniform hydrolysis and tissue integration. According to the supplied technical documentation, PDLLA has an approximate degradation period of 6–12 months and is associated with the induction of Type I and Type III collagen.
Hyaluronic Acid (HA)
Hyaluronic acid functions as a hydration and delivery matrix within the PD-H 100 composite. The supplied technical documentation describes HA as creating an immediate hydration environment while helping prevent particle aggregation and promoting more uniform polymer dispersion.
Composition
| Primary Polymer | Poly-D,L-lactic Acid (PDLLA) |
|---|---|
| Delivery Matrix | Hyaluronic Acid (HA) |
| Polymer Content | 100 mg |
| Composite | 100 mg polymer + HA |
Ingredient Disclosure: The supplied PD-H 100 technical document identifies PDLLA and Hyaluronic Acid and describes a 100 mg polymer + HA composite structure. It does not provide the complete quantitative formulation, HA concentration, excipient list, or full ingredient declaration. Refer to the manufacturer's official labeling and Instructions for Use for complete product composition.